Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Yu Pushkar

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Urologiia (Moscow, Russia : 1999)|February 12, 2019
[Imidafenacin for treatment of overactive bladder and urgent urinary incontinence: the results of open-label multicenter randomized controlled clinical trial]S H Al-Shukri, D Yu Pushkar, O I Apolikhin, et al.
Urologiia (Moscow, Russia : 1999)|July 30, 2019
[The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia]Yu A Kupriyanov, P I Rasner, I M Rokhlikov, et al.
Voprosy Onkologii|November 17, 2018
[Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)]K A Babalyan, R Sultanov, E V Generozov, et al.
Urologiia (Moscow, Russia : 1999)|June 12, 2019
[LUTS/BPH who treats?. The results of the epidemiologic study]D Yu Pushkar, P I Rasner, I A Aboyan, et al.
Urologiia (Moscow, Russia : 1999)|October 18, 2023
[Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder]I A Apolikhina, T A Teterina, O A Arefieva, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Urologiia (Moscow, Russia : 1999)|February 12, 2019
[Imidafenacin for treatment of overactive bladder and urgent urinary incontinence: the results of open-label multicenter randomized controlled clinical trial]S H Al-Shukri, D Yu Pushkar, O I Apolikhin, et al.
Urologiia (Moscow, Russia : 1999)|July 30, 2019
[The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia]Yu A Kupriyanov, P I Rasner, I M Rokhlikov, et al.
Voprosy Onkologii|November 17, 2018
[Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)]K A Babalyan, R Sultanov, E V Generozov, et al.
Urologiia (Moscow, Russia : 1999)|June 12, 2019
[LUTS/BPH who treats?. The results of the epidemiologic study]D Yu Pushkar, P I Rasner, I A Aboyan, et al.
Urologiia (Moscow, Russia : 1999)|October 18, 2023
[Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder]I A Apolikhina, T A Teterina, O A Arefieva, et al.
Pageof 8